Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Other Working Capital Changes: 2019-2025

Historic Other Working Capital Changes for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to $517,000.

  • Revolution Medicines' Other Working Capital Changes rose 111.87% to $517,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 261.74%. This contributed to the annual value of $9.7 million for FY2024, which is 317.49% up from last year.
  • Per Revolution Medicines' latest filing, its Other Working Capital Changes stood at $517,000 for Q3 2025, which was down 95.76% from $12.2 million recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Other Working Capital Changes registered a high of $12.2 million during Q2 2025, and its lowest value of -$22.8 million during Q4 2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was $517,000 (2025), whereas its average is $1.3 million.
  • In the last 5 years, Revolution Medicines' Other Working Capital Changes slumped by 569.31% in 2022 and then surged by 574.97% in 2024.
  • Over the past 5 years, Revolution Medicines' Other Working Capital Changes (Quarterly) stood at -$3.4 million in 2021, then slumped by 569.31% to -$22.8 million in 2022, then plummeted by 124.80% to -$1.4 million in 2023, then surged by 574.97% to $5.1 million in 2024, then skyrocketed by 111.87% to $517,000 in 2025.
  • Its Other Working Capital Changes was $517,000 in Q3 2025, compared to $12.2 million in Q2 2025 and -$6.4 million in Q1 2025.